Table 1:

Participant Characteristics

	NCS (N=35)	PSZ (N=38)	Statistic	p-value
Age	36.83 (11.88)	39.06 (10.34)	t=−0.827	0.411
Gender (M | F)	20| 13	23 | 13	φ =0.08	0.78
Race (African American | Caucasian | Other)	13| 19 | 1	12 |21 | 2	φ =0.37	0.83
Participant Education	15 (1.86)	13.06 (2.37)	t= 3.762	< .001
WRAT 4	110.14(14.86)	94.88(10.95)	t= 4.82	< .001
MCT Overall	50.25 (14.92)	30.49 (14.18)	t= 5.627	< .001
Total CPZ		440.7 (365.2)
BPRS Total		35.42 (7.7)
SANS Total		27.42 (12.22)

WRAT 4-Wide Range Achievement Test 4; MCT Overall-MATRICS Consensus Cognitive Battery Overall Score; CPZ-Total Chlorpromazine equivalents, calculated using the Andreasen method (Andreasen et al., 2010); BPRS-Brief Psychiatric Rating Scale; SANS-Scale for the Assessment of Negative Symptoms